These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 30400735)

  • 21. [Alterations in microRNA expression patterns in liver diseases].
    Lendvai G; Kiss A; Kovalszky I; Schaff Z
    Orv Hetil; 2010 Nov; 151(45):1843-53. PubMed ID: 20980222
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Control of Cellular Aging, Tissue Function, and Cancer by p53 Downstream of Telomeres.
    Roake CM; Artandi SE
    Cold Spring Harb Perspect Med; 2017 May; 7(5):. PubMed ID: 28289249
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cellular senescence in liver fibrosis: Implications for age-related chronic liver diseases.
    Udomsinprasert W; Sobhonslidsuk A; Jittikoon J; Honsawek S; Chaikledkaew U
    Expert Opin Ther Targets; 2021 Sep; 25(9):799-813. PubMed ID: 34632912
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Telomeric 3' overhangs in chronic HBV-related hepatitis and hepatocellular carcinoma.
    Lee JE; Oh BK; Choi J; Park YN
    Int J Cancer; 2008 Jul; 123(2):264-272. PubMed ID: 18449889
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Telomerase deletion limits progression of p53-mutant hepatocellular carcinoma with short telomeres in chronic liver disease.
    Lechel A; Holstege H; Begus Y; Schienke A; Kamino K; Lehmann U; Kubicka S; Schirmacher P; Jonkers J; Rudolph KL
    Gastroenterology; 2007 Apr; 132(4):1465-75. PubMed ID: 17433324
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatocytes in liver injury: Victim, bystander, or accomplice in progressive fibrosis?
    Tu T; Calabro SR; Lee A; Maczurek AE; Budzinska MA; Warner FJ; McLennan SV; Shackel NA
    J Gastroenterol Hepatol; 2015 Dec; 30(12):1696-704. PubMed ID: 26239824
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Telomeres: hallmarks of radiosensitivity.
    Ayouaz A; Raynaud C; Heride C; Revaud D; Sabatier L
    Biochimie; 2008 Jan; 90(1):60-72. PubMed ID: 18006207
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential timing of oxidative DNA damage and telomere shortening in hepatitis C and B virus-related liver carcinogenesis.
    Piciocchi M; Cardin R; Cillo U; Vitale A; Cappon A; Mescoli C; Guido M; Rugge M; Burra P; Floreani A; Farinati F
    Transl Res; 2016 Feb; 168():122-133. PubMed ID: 26408804
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New Mechanism of Hepatic Fibrogenesis: Hepatitis C Virus Infection Induces Transforming Growth Factor β1 Production through Glucose-Regulated Protein 94.
    Jee MH; Hong KY; Park JH; Lee JS; Kim HS; Lee SH; Jang SK
    J Virol; 2015 Dec; 90(6):3044-55. PubMed ID: 26719248
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Decreased S100B expression in chronic liver diseases.
    Baik SJ; Kim TH; Yoo K; Moon IH; Choi JY; Chung KW; Song DE
    Korean J Intern Med; 2017 Mar; 32(2):269-276. PubMed ID: 27255110
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Determination of the rate of micronucleus formation in lymphocytes in liver diseases and its clinical significance].
    Cai HF; Cai F; Fan ZP
    Zhonghua Nei Ke Za Zhi; 1991 May; 30(5):289-90, 318. PubMed ID: 1879242
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Variant adiponutrin (PNPLA3) represents a common fibrosis risk gene: non-invasive elastography-based study in chronic liver disease.
    Krawczyk M; Grünhage F; Zimmer V; Lammert F
    J Hepatol; 2011 Aug; 55(2):299-306. PubMed ID: 21168459
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Telomerase activity, telomere length and human telomerase reverse transcriptase expression in hepatocellular carcinoma is independent of hepatitis virus status.
    Saini N; Srinivasan R; Chawla Y; Sharma S; Chakraborti A; Rajwanshi A
    Liver Int; 2009 Sep; 29(8):1162-70. PubMed ID: 19627485
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Research on microRNA in liver disease and hepatic fibrosis].
    Xu MD; Li WQ; Yu HY
    Zhonghua Bing Li Xue Za Zhi; 2011 Jan; 40(1):65-7. PubMed ID: 21429367
    [No Abstract]   [Full Text] [Related]  

  • 35. Telomere/telomerase interplay in virus-driven and virus-independent lymphomagenesis: pathogenic and clinical implications.
    Dolcetti R; De Rossi A
    Med Res Rev; 2012 Mar; 32(2):233-53. PubMed ID: 20549676
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aneuploidy and asynchronous replication in non-alcholic fatty liver disease and cryptogenic cirrhosis.
    Laish I; Mannasse-Green B; Hadary R; Konikoff FM; Amiel A; Kitay-Cohen Y
    Gene; 2016 Nov; 593(1):162-166. PubMed ID: 27520584
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Telomerase activation: a potential key modulator for human healthspan and longevity.
    Boccardi V; Paolisso G
    Ageing Res Rev; 2014 May; 15():1-5. PubMed ID: 24561251
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early-life liver cirrhosis and variable clinical presentation in telomere disease.
    Faingelernt Y; Nassar R; Ling G; Kodman Y; Feuerstein T; Yerushalmi B
    Acta Paediatr; 2022 Dec; 111(12):2416-2421. PubMed ID: 36070080
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Establishment of functional telomerase immortalized human hepatocytes and a hepatic stellate cell line for telomere-targeting anticancer drug development.
    Waki K; Anno K; Ono T; Ide T; Chayama K; Tahara H
    Cancer Sci; 2010 Jul; 101(7):1678-85. PubMed ID: 20456367
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Telomere Dysfunction, Chromosomal Instability and Cancer.
    Meena J; Rudolph KL; Günes C
    Recent Results Cancer Res; 2015; 200():61-79. PubMed ID: 26376872
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.